{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:56:06Z","timestamp":1761512166446,"version":"3.32.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.yebeh.2005.04.016","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T12:44:45Z","timestamp":1130244285000},"page":"303-307","source":"Crossref","is-referenced-by-count":13,"title":["Catatonia induced by levetiracetam"],"prefix":"10.1016","volume":"8","author":[{"given":"Marie-Jos\u00e9e","family":"Chouinard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang-Khoa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Andr\u00e9e","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2005.04.016_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2005.04.016_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","article-title":"The novel antiepileptic drug levetiracetam (ucbL059) appears to act via a specific binding site in CNS membranes","volume":"286","author":"Noyer","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2005.04.016_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurons of rat hippocampal slices","volume":"306","author":"Niespodzianyl","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2005.04.016_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2005.04.016_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2005.04.016_bib6","doi-asserted-by":"crossref","unstructured":"Shorvon SD, Lowenthal A, Janz D, et al., for the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179\u201386.","DOI":"10.1111\/j.1528-1157.2000.tb00323.x"},{"key":"10.1016\/j.yebeh.2005.04.016_bib7","doi-asserted-by":"crossref","unstructured":"Ben-Menachem E, Falter U, for the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000 mg\u29f9d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276\u201383.","DOI":"10.1111\/j.1528-1157.2000.tb04605.x"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2005.04.016_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1528-1157.2001.00008.x","article-title":"Safety profile of levetiracetam","volume":"42","author":"Harden","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.04.016_bib9","unstructured":"Sadek AH, Kanner A, Montouris G, et al. Behavioral adverse events in patients receiving levetiracetam. Resume of the 54th American Academy of Neurology Annual Meeting (Denver, CO, USA);2002;04\u2013098."},{"key":"10.1016\/j.yebeh.2005.04.016_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2005.04.016_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2005.04.016_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2005.04.016_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/j.1950-6945.2003.tb00573.x","article-title":"Acute psychosis associated with levetiracetam","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2005.04.016_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1192\/bjp.161.4.558","article-title":"Catatonia and the neuroleptic malignant syndrome: a single entity?","volume":"161","author":"White","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.yebeh.2005.04.016_bib15","unstructured":"Kahlbaum KL. Catatonia (1874). Translated by Levij Y, Pridan T. Baltimore: John Hopkins Univ. Press; 1973."},{"key":"10.1016\/j.yebeh.2005.04.016_bib16","unstructured":"Bleuler E. Dementia praecox or the group of schizophrenias (1908). Translated by Zinkin J, New York: International Univ. Press; 1950."},{"key":"10.1016\/j.yebeh.2005.04.016_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","article-title":"Catatonia in psychiatric classification: a home of its own","volume":"160","author":"Taylor","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2005.04.016_bib18","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text rev. Washington, DC: American Psychiatric Association: 2000."},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2005.04.016_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/PL00014200","article-title":"The many varieties of catatonia","volume":"251","author":"Fink","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2005.04.016_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/jnp.6.2.122","article-title":"Catatonic disorder due to general medical conditions","volume":"6","author":"Carroll","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2005.04.016_bib21","series-title":"Catatonia: from psychopathology to neurobiology","first-page":"121","article-title":"Medical catatonia","author":"Carroll","year":"2004"},{"key":"10.1016\/j.yebeh.2005.04.016_bib22","first-page":"150","article-title":"A common pathogenesis of the serotonin syndrome, catatonia, and neuroleptic malignant syndrome (abstract)","volume":"13","author":"Carroll","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2005.04.016_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1092852900013365","article-title":"The universal field hypothesis of catatonia and neuroleptic malignant syndrome","volume":"5","author":"Carroll","year":"2000","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2005.04.016_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3928\/0048-5713-20000501-12","article-title":"Catatonia, lethal catatonia, and neuroleptic malignant syndrome","volume":"30","author":"Fricchione","year":"2000","journal-title":"Psychiatri Ann"},{"key":"10.1016\/j.yebeh.2005.04.016_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0010-440X(00)90135-4","article-title":"Catatonic signs in neuroleptic malignant syndrome","volume":"41","author":"Koch","year":"2000","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.yebeh.2005.04.016_bib26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/appi.ajp.161.6.1136","article-title":"Classification of catatonia","volume":"161","author":"Levin","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2005.04.016_bib27","first-page":"33","article-title":"Psychosis and peri-ictal confusional states","volume":"53","author":"Lancman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2005.04.016_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13651509809115116","article-title":"A case of periodic catatonia, due to frontal lobe epilepsy","volume":"2","author":"Leentjens","year":"1998","journal-title":"Int J Psychol Clin Pract"},{"key":"10.1016\/j.yebeh.2005.04.016_bib29","first-page":"244","article-title":"Catatonic stupor: unusual manifestation of temporal lobe epilepsy","volume":"12","author":"Kirubakaran","year":"1987","journal-title":"Psychiatr J Univ Ottawa"},{"key":"10.1016\/j.yebeh.2005.04.016_bib30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/jnnp.57.11.1419","article-title":"Epileptic seizures in patients with acute catatonic syndrome","volume":"57","author":"Primavera","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2005.04.016_bib31","series-title":"Catatonia: from psychopathology to neurobiology","first-page":"77","article-title":"Neuroimaging and neurophysiology","author":"Northoff","year":"2004"},{"key":"10.1016\/j.yebeh.2005.04.016_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1176\/jnp.6.4.358","article-title":"Frontal-subcortical circuits and neuropsychiatric disorders","volume":"6","author":"Mega","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2005.04.016_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/seiz.2000.0413","article-title":"Interictal and post-ictal psychosis in frontal lobe epilepsy: a retrospective comparison with temporal lobe epilepsy","volume":"9","author":"Adachi","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2005.04.016_bib34","first-page":"48","article-title":"Catatonia. A review of a behavioral neurologic syndrome","volume":"3","author":"Taylor","year":"1990","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.yebeh.2005.04.016_bib35","series-title":"The neuropsychiatry of epilepsy","first-page":"241","article-title":"The effects of antiepileptic drugs on behaviour","author":"Schmitz","year":"2002"},{"issue":"Suppl. 12","key":"10.1016\/j.yebeh.2005.04.016_bib36","first-page":"16","article-title":"Lorazepam treatment of psychogenic catatonia","volume":"49","author":"Salam","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.yebeh.2005.04.016_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2190\/X0FF-VU7G-QQP7-L5V7","article-title":"Somatic treatment of catatonia","volume":"25","author":"Hawkins","year":"1995","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.yebeh.2005.04.016_bib38","series-title":"Movement disorders: a neuropsychiatric approach","first-page":"201","article-title":"Catatonia","author":"Lohr","year":"1987"},{"key":"10.1016\/j.yebeh.2005.04.016_bib39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/026988119801200312","article-title":"Acute and longer-term effects of risperidone in a case of first episode catatonic schizophrenia","volume":"12","author":"Kopala","year":"1998","journal-title":"J Psychopharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505005001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505005001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T05:36:22Z","timestamp":1736055382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505005001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1525505005001770"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2005.04.016","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}